Selected article for: "affinity purification mass spectrometry and purification mass"
Author: David E. Gordon; Gwendolyn M. Jang; Mehdi Bouhaddou; Jiewei Xu; Kirsten Obernier; Matthew J O'Meara; Jeffrey Z. Guo; Danielle L. Swaney; Tia A. Tummino; Ruth Huttenhain; Robyn Kaake; Alicia L. Richards; Beril Tutuncuoglu; Helene Foussard; Jyoti Batra; Kelsey Haas; Maya Modak; Minkyu Kim; Paige Haas; Benjamin J. Polacco; Hannes Braberg; Jacqueline M. Fabius; Manon Eckhardt; Margaret Soucheray; Melanie Brewer; Merve Cakir; Michael J. McGregor; Qiongyu Li; Zun Zar Chi Naing; Yuan Zhou; Shiming Peng; Ilsa T. Kirby; James E. Melnyk; John S Chorba; Kevin Lou; Shizhong A. Dai; Wenqi Shen; Ying Shi; Ziyang Zhang; Inigo Barrio-Hernandez; Danish Memon; Claudia Hernandez-Armenta; Christopher J.P. Mathy; Tina Perica; Kala B. Pilla; Sai J. Ganesan; Daniel J. Saltzberg; Rakesh Ramachandran; Xi Liu; Sara B. Rosenthal; Lorenzo Calviello; Srivats Venkataramanan; Yizhu Lin; Stephanie A. Wankowicz; Markus Bohn; Phillip P. Sharp; Raphael Trenker; Janet M. Young; Devin A. Cavero; Joseph Hiatt; Theo Roth; Ujjwal Rathore; Advait Subramanian; Julia Noack; Mathieu Hubert; Ferdinand Roesch; Thomas Vallet; Björn Meyer; Kris M. White; Lisa Miorin; Oren S. Rosenberg; Kliment A. Verba; David Agard; Melanie Ott; Michael Emerman; Davide Ruggero; Adolfo Garcí-Sastre; Natalia Jura; Mark von Zastrow; Jack Taunton; Olivier Schwartz; Marco Vignuzzi; Christophe d'Enfert; Shaeri Mukherjee; Matt Jacobson; Harmit S. Malik; Danica G Fujimori; Trey Ideker; Charles S Craik; Stephen Floor; James S. Fraser; John Gross; Andrej Sali; Tanja Kortemme; Pedro Beltrao; Kevan Shokat; Brian K. Shoichet; Nevan J. Krogan
Title: A SARS-CoV-2-Human Protein-Protein Interaction Map Reveals Drug Targets and Potential Drug-Repurposing
  • Document date: 2020_3_22
    • ID: 38d6gb7o_26
    Snippet: We have used affinity purification-mass spectrometry to identify 332 high-confidence SARS-CoV-2human PPIs. We find the viral proteins connected to a wide array of biological processes, including protein trafficking, translation, transcription and ubiquitination regulation. Using a combination of a systematic chemoinformatic drug search with a pathway centric analysis, we uncovered close to 70 different drugs and compounds, including FDA approved .....
    Document: We have used affinity purification-mass spectrometry to identify 332 high-confidence SARS-CoV-2human PPIs. We find the viral proteins connected to a wide array of biological processes, including protein trafficking, translation, transcription and ubiquitination regulation. Using a combination of a systematic chemoinformatic drug search with a pathway centric analysis, we uncovered close to 70 different drugs and compounds, including FDA approved drugs, compounds in clinical trials as well as preclinical compounds, targeting parts of the resulting network. We are currently testing these compounds for antiviral activity and encourage others to do the same as well as extract insights from the map that could have therapeutic value.

    Search related documents:
    Co phrase search for related documents
    • affinity purification mass spectrometry and high confidence: 1, 2, 3, 4, 5
    • affinity purification mass spectrometry and high confidence SARS: 1, 2
    • antiviral activity and biological process: 1
    • antiviral activity and clinical trial: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • antiviral activity and different drug: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
    • antiviral activity and drug search: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • antiviral activity and high confidence: 1
    • antiviral activity and high confidence SARS: 1
    • antiviral activity and preclinical compound: 1
    • approve drug and clinical trial: 1
    • approve drug and FDA approve drug: 1
    • biological process and centric analysis: 1
    • biological process and clinical trial: 1
    • biological process and high confidence: 1, 2
    • clinical trial and different drug: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • clinical trial and drug search: 1, 2, 3, 4
    • clinical trial and high confidence: 1, 2, 3, 4, 5
    • clinical trial and preclinical compound: 1
    • different drug and drug search: 1, 2, 3, 4